Infectious morbidity in critically ill patients with cancer.
about
Pneumococcal vaccines for prevention of Streptococcus pneumoniae disease in patients undergoing chemotherapy and/or radiotherapyPneumococcal vaccines for prevention of Streptococcus pneumoniae disease in patients undergoing chemotherapy and/or radiotherapyPneumonia in the neutropenic cancer patientMurine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in SepsisCancer causes increased mortality and is associated with altered apoptosis in murine sepsis.Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexiaProspective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York CSevere novel influenza A (H1N1) infection in cancer patients.Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocolsListeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection.Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997).Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005).Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.Candida infections among neutropenic patients.Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazoleCancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burdenPathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer.Tuberculosis and malignancy.Early surgical intervention for spinal infection in patients with malignancy requiring chemotherapy: report of two cases and review of the literature.Bloodstream infections in patients with solid tumors.Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.Discovery and development of educational strategies to encourage safe food handling behaviors in cancer patients.Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection.Bloodstream infections in patients with or without cancer in a large community hospital.Head and neck cancer associated with increased rate of pulmonary tuberculosis in a population-based cohort study.Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL.Pre-existing malignancy results in increased prevalence of distinct populations of CD4+ T cells during sepsis.High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies.Guidelines for diagnosing and treating pulmonary infiltrates in children with acute leukaemia: impact of timely decisions.
P2860
Q24234112-2D4FF38A-B76B-4416-8540-CA93E377BEC9Q24240374-0397C053-A6ED-4339-8466-C5807709719DQ26827758-9D408589-80E6-4745-A7A9-698D442503C2Q28551029-6C01DF24-48D9-478E-8520-11D3729A6E33Q33672565-E28B3782-3E2E-4A14-BA55-FD35C1AA5BCEQ33834933-913AD376-DC62-442C-94EB-DD546F90B60EQ34144493-E1BC5CA7-5524-4B80-828D-D8168827FB83Q34345177-328DBC3D-7AA4-480B-87E1-1C3207497BC9Q34346429-B3B49875-E3A1-42B6-A3FD-C920A6E84A17Q34702400-C6F67575-EC03-4568-88FD-DD0586F84105Q34749134-99204992-5260-45B3-8C61-E51AD9A4D85CQ36295075-9FC06EE8-A513-47EF-9F25-7003939E628AQ36568458-97357FF2-5675-4D59-8F8A-E2A3E683453DQ36861572-B16CD997-3163-45FD-A8C6-B998F1DBD136Q37020632-C16ADC45-B562-40F7-8868-EC8A5737760DQ37055211-8305701B-2F9C-498B-98F4-E2F88397A67DQ37261224-237C5F34-764D-4BDE-B47E-AEDAC9625FBCQ37300655-51A5C213-9877-4E0C-8911-7D0F2A3298B4Q37440871-578BC2F4-0CF4-4A15-811C-C8163788FC20Q37760977-3652E98E-B091-4C6E-A604-B31D2357B9B1Q38081742-4578CE94-3E95-43AD-98FA-C7D6186593F9Q38703440-7D0E2576-F9C4-49AA-A592-47FEF66A8F05Q39287519-F691AA31-982E-4E4D-A6FE-4623C4E2734CQ44061206-7F1D1958-3157-47B6-A997-FFB8E19C6BF7Q45402381-AA455696-F815-47F7-BB59-F0585F1FD4BDQ46747690-925D23D0-F692-46A8-8517-291701382F99Q47164633-3FE9F8CF-5DDD-4EAF-9BB3-D2572AC986CFQ48200992-828D0FD8-0DFB-4F3F-A9A1-3BDF55A182D5Q48235160-7B09F59B-22A6-4B7B-81A9-ED980661C217Q51186226-CDF6DB1A-0DC9-4E40-80D2-2735A5DCBC03Q51694541-0393CC10-4FDB-4D20-BFAB-18CD1B1C2DE3Q51887948-5525FCD6-B7B6-495B-A729-5622D35C4E87
P2860
Infectious morbidity in critically ill patients with cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Infectious morbidity in critically ill patients with cancer.
@ast
Infectious morbidity in critically ill patients with cancer.
@en
Infectious morbidity in critically ill patients with cancer.
@nl
type
label
Infectious morbidity in critically ill patients with cancer.
@ast
Infectious morbidity in critically ill patients with cancer.
@en
Infectious morbidity in critically ill patients with cancer.
@nl
prefLabel
Infectious morbidity in critically ill patients with cancer.
@ast
Infectious morbidity in critically ill patients with cancer.
@en
Infectious morbidity in critically ill patients with cancer.
@nl
P1476
Infectious morbidity in critically ill patients with cancer.
@en
P2093
P304
531-70, vii-viii
P356
10.1016/S0749-0704(05)70198-6
P577
2001-07-01T00:00:00Z